DÄ internationalArchive40/2007Unremarkable ECGs in Hypertensive Patients Can Mislead


Unremarkable ECGs in Hypertensive Patients Can Mislead

Dtsch Arztebl 2007; 104(40): A-2730

Werdan, K

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Lip GYH, Felmeden DC, Li-Saw-Hee FL, Beevers DG: Hypertensive heart disease. European Heart J 2000; 21: 1653–65. MEDLINE
2. Lenstrup M, Kjaergaard J, Petersen CL, Kjaer A, Hassager C: Evaluation of left ventricular mass measured by 3D echocardiography using magnetic resonance imaging as gold standard. Scand J Clin Lab Invest 2006; 66: 647–58. MEDLINE
3. Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M: New gender-specific partition values for ECG criteria of left ventricular hypertrophy – recalibration against cardiac MRI. Hypertension 2004; 44: 175–9. MEDLINE
4. Chinali M, De Marco M, D'Addeo G, Benincasa M, Romano C, Galderisi M, de Simone G: Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities. J Hypertension 2007; 25: 1073–8. MEDLINE
5. Koren MJ, Devereux RB, Casale PN et al.: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–52. MEDLINE
6. Kannel WB, d'Agostini RB, Levy D, Belanger AR: Prognostic significance of regression of left ventricular hypertrophy. Circulation 1988; (Suppl. 2): 78.
7. Okin PM, Devereux RB, Jern S et al.: Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The LIFE Study. Circulation 2003; 108: 684–90. MEDLINE
8. Okin PM, Wachtell K, Devereux RB et al.: Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 2006; 296: 1242–8. MEDLINE
9. Solomon SD, Janardhanan R, Verma A et al.: For the Valsartan In Diastolic Dysfunction (VALIDD) Investigators: Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomized trial. Lancet 2007; 369: 2079–86. MEDLINE
10. Palmieri V, Okin PM, de Simone G et al.: Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertension 2007; 25: 1079–85. MEDLINE